Personal profile


Clinical psychiatry; psychopathology; psychosis; neuropsychiatry; neuroimaging; structural magnetic resonance imaging; psychopharmacology; antipsychotics; side-effects of antipsychotic medication


Main research areas

Multimodal cohort studies on antipsychotic-naïve patients with first episode psychosis, with particular focus on structural and neurochemical brain changes after antipsychotic treatment; Physiological effects of GLP-1 analogue treatment of obesity in schizophrenia patients


Current research

Multimodal- and multivariate analyses of first episode antipsychotic naive patients; studies on metabolic side-effects of antipsychotic medication; diffusion tensor imaging (DTI) studies on patients at high risk for psychosis and first episode patients; studies on physiological effects of GLP-1 analogue treatment of obesity in schizophrenia patients (a randomized controlled trial)


Potential conflicts of interest

Lecture fees and/or is part of Advisory Boards of Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Otsuka Pharma Scandinavia and Takeda Pharmaceutical Company



Dive into the research topics where Bjørn Hylsebeck Ebdrup is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or